BELITE BIO INC - AMERICAN DEPOSITARY SHARES
48.60
08-يوليو-24 15:59:47
15 متأخرة بدقائق
الأسهم
+3.10
+6.81%
نطاق اليوم
45.70 - 49.10
ISIN
N/A
المصدر
NASDAQ
-
06 نوفمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting
27 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results
08 أغسطس 2023 22:17:28 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on August 9, 2023 to Discuss Second Quarter 2023 Financial Results
04 أغسطس 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Doses First Subject in Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant for GA
27 يوليو 2023 17:00:00 بحسب Nasdaq GlobeNewswire
-
30 مايو 2023 20:49:26 بحسب Nasdaq GlobeNewswire
-
30 مايو 2023 16:01:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Reports First-Quarter 2023 Operational Highlights and Financial Results
10 مايو 2023 19:58:59 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on May 11, 2023 to Discuss First Quarter 2023 Financial Results
10 مايو 2023 15:33:22 بحسب Nasdaq GlobeNewswire
-
04 مايو 2023 11:09:06 بحسب Nasdaq GlobeNewswire
-
25 أبريل 2023 16:30:00 بحسب Nasdaq GlobeNewswire
-
11 أبريل 2023 09:00:01 بحسب Nasdaq GlobeNewswire
-
Belite Bio Reports Full-Year 2022 Operational Highlights and Financial Results
31 مارس 2023 19:03:37 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on April 3, 2023 to Discuss 2022 Full Year Financial Results
31 مارس 2023 12:57:14 بحسب Nasdaq GlobeNewswire
-
18 نوفمبر 2022 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio to Host Key Opinion Leader Webinar on October 27, 2022 to discuss LBS-008 Interim Data
20 أكتوبر 2022 08:00:01 بحسب Nasdaq GlobeNewswire
-
01 أكتوبر 2022 19:03:33 بحسب Nasdaq GlobeNewswire
-
23 سبتمبر 2022 08:00:00 بحسب Nasdaq GlobeNewswire
-
Belite Bio Receives Approval of LBS-008 Phase 3 Clinical Trial in China
16 سبتمبر 2022 08:00:32 بحسب Nasdaq GlobeNewswire
-
Belite Bio Initiates Pivotal Phase 3 Clinical Trial of LBS-008 in Stargardt Disease in the U.S.
22 أغسطس 2022 08:00:00 بحسب Nasdaq GlobeNewswire